(S)-3-((1-methylpyrrolidin-2-yl)methyl)-5-(2-(phenylsulfonyl)ethyl)-1H-indole-d3 n IX BrH/c1-26(2)21-6-5-19(22(26)16-21)7-11-31-12-8-28(9-13-32-14-10-28)18-20-15-24(29-3)25(30-4)17-23(20)27

BrH/c1-26(2)21-6-5-19(22(26)16-21)7-11-31-12-8-28(9-13-32-14-10-28)18-20-15-24(29-3)25(30-4)17-23(20)27

a consequence of having end-stage renal disease

MISO pretreatment could result in a greater amount of binding of MEL to DNA at early times after injection

5 µg/mL for inhibiting HCV infection

(S)-3-((1-methylpyrrolidin-2-yl)methyl)-5-(2-(phenylsulfonyl)ethyl)-1H-indole-d3 n IX BrH/c1-26(2)21-6-5-19(22(26)16-21)7-11-31-12-8-28(9-13-32-14-10-28)18-20-15-24(29-3)25(30-4)17-23(20)27Product information CAS Number: 1217698 26 4 Molecular Weight: 385. 54 Formula: C22H26N2O2S Chemical Name: 5 [2 (benzenesulfonyl)ethyl] 3 {[(2S) 1 (H)methylpyrrolidin 2 yl]methyl} 1H indole Smiles: [2H]C([2H])([2H])N1CCC[C@H]1CC1=CNC2=CC=C(CCS(=O)(=O)C3C=CC=CC=3)C=C12 InChiKey: PWVXXGRKLHYWKM COJYBMMNSA N InChi: InChI=1S C22H26N2O2S c1 24 12 5 6 19(24)15 18 16 23 22 10 9 17(14 21(18)22)11 13 27(25,26)20 7 3 2 4 8 20 h2 4,7 10,14,16,19,23H,5 6,11